Quality and Regulatory Overview

Quality assurance, quality control and regulatory affairs

Quality Control

At each of our sites, the Quality Control group operates a stringent system for release testing of raw materials, packaging materials, in process controls and final products through the use of the most modern analytical techniques and equipment supported by highly trained and experienced personnel.  QC also undertake reference standard certification in compliance with cGMP regulations.

Quality Assurance

At each of our sites, the Quality Assurance group, independent of production, is responsible for the maintenance, compliance and further development of our internal quality management system. The Quality Assurance group guarantees that the pharmaceutical ingredients and other products comply with the respective requirements and are developed, produced, tested and released according to cGMP demands.

Regulatory Affairs

Dishman support customers through New Drug Application (NDA) to in-market supply. We assist our clients with regulatory filing processes by providing full support in the compilation and maintenance of regulatory documentation including chemistry, manufacturing and control documentation, post-approval change documentation, type II Drug Master Files (DMFs), Certifications of Suitability to the Monographs of the European Pharmacopoeia (CEPs) and Active Substance Master Files for Europe (ASMFs).


9 February 2015
Successful FDA inspection at the Netherlands Dishman site

3 October 2014
CEO Mark Griffiths Appointed to Dishman Board of Directors

14 April 2014
Dishman Continues to Invest in Expanding High Potency Capabilities

1 April 2014
Appointment of Global Chief Financial Officer

10 March 2014
Clarification on reports in the media on the sale of the Shanghai plant